![Vaccine efficacy against severe COVID-19 in relation to delta variant (B.1.617.2) and time since second dose in patients in Scotland (REACT-SCOT): a case-control study - The Lancet Respiratory Medicine Vaccine efficacy against severe COVID-19 in relation to delta variant (B.1.617.2) and time since second dose in patients in Scotland (REACT-SCOT): a case-control study - The Lancet Respiratory Medicine](https://www.thelancet.com/cms/asset/00be3fb5-fa82-4da2-a7a9-39531ac92e64/gr1.jpg)
Vaccine efficacy against severe COVID-19 in relation to delta variant (B.1.617.2) and time since second dose in patients in Scotland (REACT-SCOT): a case-control study - The Lancet Respiratory Medicine
![COVID-19 Vaccine Second-Dose Completion and Interval Between First and Second Doses Among Vaccinated Persons — United States, December 14, 2020−February 14, 2021 | MMWR COVID-19 Vaccine Second-Dose Completion and Interval Between First and Second Doses Among Vaccinated Persons — United States, December 14, 2020−February 14, 2021 | MMWR](https://www.cdc.gov/mmwr/volumes/70/wr/social-media/mm7011e2_COVID19VaccineDose2_IMAGE_12Mar21_v4_1200x627.jpg?_=39294)
COVID-19 Vaccine Second-Dose Completion and Interval Between First and Second Doses Among Vaccinated Persons — United States, December 14, 2020−February 14, 2021 | MMWR
![Two-dose ChAdOx1 nCoV-19 vaccine protection against COVID-19 hospital admissions and deaths over time in Scotland & Brazil | The University of Edinburgh Two-dose ChAdOx1 nCoV-19 vaccine protection against COVID-19 hospital admissions and deaths over time in Scotland & Brazil | The University of Edinburgh](https://www.ed.ac.uk/sites/default/files/styles/landscape_breakpoints_theme_uoe_mobile_1x/public/thumbnails/image/eave_ii_-_lancet_-_vaccine_waning_infographic_-_dec_2021.png?itok=3Qkrzk-0)
Two-dose ChAdOx1 nCoV-19 vaccine protection against COVID-19 hospital admissions and deaths over time in Scotland & Brazil | The University of Edinburgh
![Vaccines | Free Full-Text | The Four Ws of the Fourth Dose COVID-19 Vaccines: Why, Who, When and What Vaccines | Free Full-Text | The Four Ws of the Fourth Dose COVID-19 Vaccines: Why, Who, When and What](https://www.mdpi.com/vaccines/vaccines-10-01924/article_deploy/html/images/vaccines-10-01924-g001.png)
Vaccines | Free Full-Text | The Four Ws of the Fourth Dose COVID-19 Vaccines: Why, Who, When and What
![Public health impact of delaying second dose of BNT162b2 or mRNA-1273 covid-19 vaccine: simulation agent based modeling study | The BMJ Public health impact of delaying second dose of BNT162b2 or mRNA-1273 covid-19 vaccine: simulation agent based modeling study | The BMJ](https://www.bmj.com/content/bmj/373/bmj.n1087/F5.medium.jpg)
Public health impact of delaying second dose of BNT162b2 or mRNA-1273 covid-19 vaccine: simulation agent based modeling study | The BMJ
![TODAY: Registration Opens for Curative Second Dose COVID-19 Vaccination Events - State of Delaware News TODAY: Registration Opens for Curative Second Dose COVID-19 Vaccination Events - State of Delaware News](https://news.delaware.gov/files/2021/02/Updates-on-COVID-19-Vaccination-Program-1-1.png)
TODAY: Registration Opens for Curative Second Dose COVID-19 Vaccination Events - State of Delaware News
![COVID vaccinations: questions and answers about the rollout in North Yorkshire - NHS North Yorkshire CCG COVID vaccinations: questions and answers about the rollout in North Yorkshire - NHS North Yorkshire CCG](https://northyorkshireccg.nhs.uk/wp-content/uploads/2022/01/Covid-Vaccine-Eligibility-v4-scaled.jpg)
COVID vaccinations: questions and answers about the rollout in North Yorkshire - NHS North Yorkshire CCG
![Delaying second dose of Pfizer vaccine too long could boost infections and deaths, study warns | National Post Delaying second dose of Pfizer vaccine too long could boost infections and deaths, study warns | National Post](https://smartcdn.gprod.postmedia.digital/nationalpost/wp-content/uploads/2021/02/COVID-chart.png)
Delaying second dose of Pfizer vaccine too long could boost infections and deaths, study warns | National Post
![Effect of Delta variant on viral burden and vaccine effectiveness against new SARS-CoV-2 infections in the UK | Nature Medicine Effect of Delta variant on viral burden and vaccine effectiveness against new SARS-CoV-2 infections in the UK | Nature Medicine](https://media.springernature.com/full/springer-static/image/art%3A10.1038%2Fs41591-021-01548-7/MediaObjects/41591_2021_1548_Fig1_HTML.png)
Effect of Delta variant on viral burden and vaccine effectiveness against new SARS-CoV-2 infections in the UK | Nature Medicine
![expert reaction to preprint from Oxford looking at immunogenicity and efficacy of the Oxford/AstraZeneca vaccine with a 3-month gap between doses, and looking at whether data says anything about transmission | Science expert reaction to preprint from Oxford looking at immunogenicity and efficacy of the Oxford/AstraZeneca vaccine with a 3-month gap between doses, and looking at whether data says anything about transmission | Science](http://www.sciencemediacentre.org/wp-content/uploads/2021/02/Sheila-Bird-03-02-2021.png)
expert reaction to preprint from Oxford looking at immunogenicity and efficacy of the Oxford/AstraZeneca vaccine with a 3-month gap between doses, and looking at whether data says anything about transmission | Science
![COVID-19 Vaccine Second-Dose Completion and Interval Between First and Second Doses Among Vaccinated Persons — United States, December 14, 2020−February 14, 2021 | MMWR COVID-19 Vaccine Second-Dose Completion and Interval Between First and Second Doses Among Vaccinated Persons — United States, December 14, 2020−February 14, 2021 | MMWR](https://www.cdc.gov/mmwr/volumes/70/wr/figures/mm7011e2-F.gif?_=83873)
COVID-19 Vaccine Second-Dose Completion and Interval Between First and Second Doses Among Vaccinated Persons — United States, December 14, 2020−February 14, 2021 | MMWR
![Public health impact of delaying second dose of BNT162b2 or mRNA-1273 covid-19 vaccine: simulation agent based modeling study | The BMJ Public health impact of delaying second dose of BNT162b2 or mRNA-1273 covid-19 vaccine: simulation agent based modeling study | The BMJ](https://www.bmj.com/content/bmj/373/bmj.n1087/F2.medium.jpg)